Quality System

Quality you can trust in every batch.

Integrated Approach to Pharmaceutical Excellence

Quality Assurance & Quality Control

At Cerata Pharmaceuticals LLP, Quality Assurance and Quality Control are central to every stage of API manufacturing across Steroid, Hormone, Oncology, and Peptide product lines. A unified and independent Quality Management System (QMS) governs development, scale-up, commercial production, and long-term supply, ensuring full compliance with global regulatory expectations.

Quality Assurance (QA)

Independent oversight for compliance and excellence

Quality Assurance at Cerata Pharmaceuticals LLP functions independently across development laboratories, manufacturing units, and quality control operations. QA oversees a comprehensive QMS aligned with WHO-GMP and cGMP guidelines, ensuring controlled, compliant, and reproducible manufacturing.

  1. Integrated QMS aligned with WHO-GMP and cGMP guidelines
  2. Independent QA oversight across manufacturing and laboratories
  3. End-to-end batch traceability and lifecycle management
  4. Vendor qualification and contract laboratory assessment
  5. Support for DMF and regulatory submission documentation for global markets
  6. Data integrity governance and audit readiness
  7. Change management, deviation investigation, and CAPA implementation
  8. Process and cleaning validation oversight
  9. Quality risk management and lifecycle control

Our QA systems are designed to exceed regulatory expectations, ensuring consistent product integrity, controlled manufacturing environments, and sustainable quality performance.

Quality Control (QC)

Analytical excellence for product verification

Cerata Pharmaceuticals LLP operates advanced, fully in-house Quality Control laboratories supporting Steroid, Hormone, Oncology, and Peptide API manufacturing. QC activities cover the complete product lifecycle, including raw materials, in-process samples, intermediates, finished APIs, cleaning verification, water systems, and environmental monitoring.

  1. Raw material qualification and vendor approval programs
  2. In-process control and critical parameter monitoring
  3. Intermediate and finished API testing and release
  4. Validated analytical methods ensuring accuracy and reproducibility
  5. Stability studies supporting shelf life and regulatory filings as per ICH guidelines
  6. Cleaning verification and cross-contamination control
  7. Water system testing and environmental monitoring
  8. Out-of-specification (OOS) investigation
  9. Compliance with pharmacopoeial standards (USP, EP, JP)

Our QC teams ensure analytical reliability and data accuracy, providing the scientific foundation for product quality and regulatory compliance.

Analytical Infrastructure

State-of-the-Art Quality Control Laboratories

Our QC laboratories are equipped with modern and high-precision analytical instrumentation, ensuring accurate, reliable, and compliant testing for all product lines.

Quality Control Laboratory

Commitment to Analytical Excellence

This centralized QA/QC system enables Cerata to consistently deliver high-quality APIs with proven reliability and compliance for global pharmaceutical markets.

  1. All analytical methods are fully validated as per regulatory guidelines
  2. Routine calibration and qualification of analytical instruments
  3. Continuous stability monitoring under ICH-compliant conditions
  4. Strict adherence to global QA/QC and data integrity standards
  5. Ensures batch-to-batch consistency and regulatory confidence

Quality Focus by API Category

Specialized Quality Control Strategies for Different Therapeutic Classes

Each API category requires unique quality considerations. Our specialized Quality Control strategies ensure that every product line meets the highest standards of safety, efficacy, and regulatory compliance.

Endocrine-active molecules

Steroid & Hormone APIs

Steroid and Hormone API manufacturing demands precise control over chemistry, dosage uniformity, and impurity profiles. Cerata applies specialized quality control strategies to ensure consistent quality and safety of endocrine-active molecules.

  • Strict isomer ratio and stereochemical control
  • Low-dose uniformity and cross-contamination prevention
  • Multi-stage crystallization and purification validation
  • Impurity trend analysis across commercial batches
  • Dedicated analytical methods for steroid-specific impurities
  • Fermentation process monitoring for biotransformation yield and microbial strain control

High-potency compounds

Oncology APIs

Oncology APIs are manufactured under enhanced quality and safety frameworks due to their high potency and cytotoxic nature, requiring stringent controls and specialized handling.

  • Trace-level impurity and genotoxic impurity monitoring
  • High-sensitivity analytical testing for potent compounds
  • Segregated quality review for cytotoxic operations
  • Strict containment verification and cleaning validation
  • Batch reproducibility under low occupational exposure limits

Molecular-level accuracy

Peptide APIs

Peptide APIs require molecular-level accuracy and sequence fidelity, supported by advanced analytical and process controls to ensure purity and biological activity.

  • Sequence confirmation and peptide mapping
  • In-process QC of solid-phase peptide synthesis (SPPS)
  • Purity profiling using high-resolution chromatography
  • Molecular weight confirmation via mass spectrometry
  • Control of deletion, truncation, and aggregation impurities
  • Reproducible synthesis validation from R&D to commercial scale

Regulatory Approvals & Certifications

Compliance with Global Standards

Cerata Pharmaceuticals LLP operates manufacturing facilities that comply with internationally accepted regulatory and quality standards, supporting both regulated and semi-regulated markets.

Partnership Enablement

This regulatory-driven manufacturing approach enables seamless customer qualification, efficient technology transfer, and long-term commercial partnerships with multinational pharmaceutical companies.

Audits & Compliance

  • Successful customer and third-party audits by global pharma companies
  • Strong EHS, sustainability, and compliance culture
  • Audit-ready documentation and regulatory transparency

Certifications & Standards

  • WHO-GMP compliant manufacturing facilities
  • cGMP-aligned operations across all API categories
  • ISO 9001:2015 certified Quality Management System

Stability Studies

Ensuring Product Integrity Throughout Shelf Life

Stability testing is a critical component of Cerata Pharmaceuticals LLP's quality assurance and regulatory compliance strategy. All stability studies are conducted in accordance with ICH Q1 guidelines to establish product shelf life, storage conditions, and ongoing product integrity.

ICH-Compliant Stability Chambers

State-of-the-art chambers with 24/7 continuous monitoring for long-term, intermediate, and accelerated stability studies.

Comprehensive Testing

Stability evaluation of Steroid, Hormone, Oncology, and Peptide APIs with stability indicating analytical methods.

Regulatory Support

Stability data support for regulatory filings, DMFs, and customer submissions.

Stability Study Types:

  • Long-term
  • Intermediate
  • Accelerated
  • Ongoing

Quality Risk Management & Product Quality Reviews

Proactive quality assurance for continuous improvement.

Quality Risk Management

Aligning with ICH Principles

Cerata follows a structured, risk-based Quality Risk Management approach aligned with ICH principles. Process design, scale-up, and commercial manufacturing are supported by continuous risk assessment to identify, evaluate, and control critical quality attributes and process parameters.

Changes introduced during development or lifecycle management are treated as controlled opportunities for process optimization, ensuring enhanced process understanding without compromising product quality or compliance.

  1. 01 Control of critical quality attributes
  2. 02 Critical quality attributes
  3. 03 Controlled process optimization

Product Quality Reviews (PQR)

Comprehensive Quality Assessment

Comprehensive Product Quality Reviews are conducted for Steroid, Hormone, Oncology, and Peptide APIs to assess manufacturing consistency, analytical trends, stability performance, and process robustness.

  • 01

    Trend analysis of batch manufacturing and analytical data

  • 02

    Evaluation of critical quality parameters

  • 03

    Review of deviations, complaints, and corrective actions

  • 04

    Recommendations for continuous improvement

These reviews reinforce Cerata's commitment to consistent quality, regulatory transparency, and continuous improvement.

Self-Inspection & Our Strengths

Audit readiness and quality excellence

Self-Inspection & Audit Readiness

A structured self-inspection program, managed by Quality Assurance, ensures continuous adherence to cGMP requirements. Annual audit plans are executed by trained, cross-functional teams, with clearly defined corrective and preventive actions tracked to closure.

Proven audit record

Cerata's manufacturing facilities have successfully undergone multiple customer audits covering Quality, EHS, and sustainability, reinforcing confidence among multinational pharmaceutical partners.

This disciplined and science-driven quality approach enables Cerata Pharmaceuticals LLP to consistently deliver high-purity, compliant, and reliable APIs for regulated and semi-regulated pharmaceutical markets worldwide.

Our strength

Fully In-House QC

Complete analytical testing capabilities within our facilities.

API-Specific Controls

Tailored controls for Steroid, Hormone, Oncology, and Peptide products.

Risk-Based Quality

Aligned with global guidelines and best practices.

Audit Readiness

Regulatory transparency and audit-ready documentation.

Exceeding Standards

Internal quality standards set above minimum regulatory requirements.